These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 33965302)
1. Clinical and genetic spectrum of a Chinese cohort with SCN4A gene mutations. Sun J; Luo S; Suetterlin KJ; Song J; Huang J; Zhu W; Xi J; Zhou L; Lu J; Lu J; Zhao C; Hanna MG; Männikkö R; Matthews E; Qiao K Neuromuscul Disord; 2021 Sep; 31(9):829-838. PubMed ID: 33965302 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands. Stunnenberg BC; Raaphorst J; Deenen JCW; Links TP; Wilde AA; Verbove DJ; Kamsteeg EJ; van den Wijngaard A; Faber CG; van der Wilt GJ; van Engelen BGM; Drost G; Ginjaar HB Neuromuscul Disord; 2018 May; 28(5):402-407. PubMed ID: 29606556 [TBL] [Abstract][Full Text] [Related]
3. Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis. Corrochano S; Männikkö R; Joyce PI; McGoldrick P; Wettstein J; Lassi G; Raja Rayan DL; Blanco G; Quinn C; Liavas A; Lionikas A; Amior N; Dick J; Healy EG; Stewart M; Carter S; Hutchinson M; Bentley L; Fratta P; Cortese A; Cox R; Brown SD; Tucci V; Wackerhage H; Amato AA; Greensmith L; Koltzenburg M; Hanna MG; Acevedo-Arozena A Brain; 2014 Dec; 137(Pt 12):3171-85. PubMed ID: 25348630 [TBL] [Abstract][Full Text] [Related]
4. Prevalence study of genetically defined skeletal muscle channelopathies in England. Horga A; Raja Rayan DL; Matthews E; Sud R; Fialho D; Durran SC; Burge JA; Portaro S; Davis MB; Haworth A; Hanna MG Neurology; 2013 Apr; 80(16):1472-5. PubMed ID: 23516313 [TBL] [Abstract][Full Text] [Related]
5. Mutation spectrum and health status in skeletal muscle channelopathies in Japan. Sasaki R; Nakaza M; Furuta M; Fujino H; Kubota T; Takahashi MP Neuromuscul Disord; 2020 Jul; 30(7):546-553. PubMed ID: 32660787 [TBL] [Abstract][Full Text] [Related]
6. Mutations of SCN4A gene cause different diseases: 2 case reports and literature review. Liu XL; Huang XJ; Luan XH; Zhou HY; Wang T; Wang JY; Chen SD; Tang HD; Cao L Channels (Austin); 2015; 9(2):82-7. PubMed ID: 25839108 [TBL] [Abstract][Full Text] [Related]
7. Overlap of periodic paralysis and paramyotonia congenita caused by SCN4A gene mutations two family reports and literature review. Huang S; Zhang W; Chang X; Guo J Channels (Austin); 2019 Dec; 13(1):110-119. PubMed ID: 30931713 [TBL] [Abstract][Full Text] [Related]
8. N1366S mutation of human skeletal muscle sodium channel causes paramyotonia congenita. Ke Q; Ye J; Tang S; Wang J; Luo B; Ji F; Zhang X; Yu Y; Cheng X; Li Y J Physiol; 2017 Nov; 595(22):6837-6850. PubMed ID: 28940424 [TBL] [Abstract][Full Text] [Related]
9. Mutations in the muscle sodium channel gene (SCN4A) in 13 French families with hyperkalemic periodic paralysis and paramyotonia congenita: phenotype to genotype correlations and demonstration of the predominance of two mutations. Plassart E; Reboul J; Rime CS; Recan D; Millasseau P; Eymard B; Pelletier J; Thomas C; Chapon F; Desnuelle C Eur J Hum Genet; 1994; 2(2):110-24. PubMed ID: 8044656 [TBL] [Abstract][Full Text] [Related]
10. SCN4A variants and Brugada syndrome: phenotypic and genotypic overlap between cardiac and skeletal muscle sodium channelopathies. Bissay V; Van Malderen SC; Keymolen K; Lissens W; Peeters U; Daneels D; Jansen AC; Pappaert G; Brugada P; De Keyser J; Van Dooren S Eur J Hum Genet; 2016 Mar; 24(3):400-7. PubMed ID: 26036855 [TBL] [Abstract][Full Text] [Related]
11. p.Asn1180Ile mutation of SCN4A gene in an Italian family with myopathy and myotonic syndrome. Rigamonti A; Mantero V; Peverelli L; Pagliarani S; Lucchiari S; Comi G; Gibertini S; Salmaggi A Neurol Sci; 2021 Dec; 42(12):5359-5363. PubMed ID: 34378097 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of genetically confirmed skeletal muscle channelopathies in the era of next generation sequencing. Vivekanandam V; Jaibaji R; Sud R; Ellmers R; Skorupinska I; Germaine L; James N; Holmes S; Mannikko R; Jayaseelan D; Hanna MG Neuromuscul Disord; 2023 Mar; 33(3):270-273. PubMed ID: 36796140 [TBL] [Abstract][Full Text] [Related]
13. Diagnostics in skeletal muscle channelopathies. Vicino A; Brugnoni R; Maggi L Expert Rev Mol Diagn; 2023; 23(12):1175-1193. PubMed ID: 38009256 [TBL] [Abstract][Full Text] [Related]
15. [Normokalemic periodic paralysis lasting for two weeks: a severe form of sodium channelopathy with M1592V mutation]. Shiga K; Mizuta I; Noto Y; Nakagawa M; Sasaki R; Yamawaki M Rinsho Shinkeigaku; 2014; 54(5):434-9. PubMed ID: 24943082 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic variability in childhood of skeletal muscle sodium channelopathies. Yoshinaga H; Sakoda S; Shibata T; Akiyama T; Oka M; Yuan JH; Takashima H; Takahashi MP; Kitamura T; Murakami N; Kobayashi K Pediatr Neurol; 2015 May; 52(5):504-8. PubMed ID: 25724373 [TBL] [Abstract][Full Text] [Related]
18. [Clinical and molecular genetic analysis of a family with normokalemic periodic paralysis]. Wei CJ; Wang D; Wang S; Jiao H; Hong DJ; Pu LH; Xiong H Zhonghua Er Ke Za Zhi; 2013 Jan; 51(1):47-51. PubMed ID: 23527931 [TBL] [Abstract][Full Text] [Related]
20. [Analysis of SCN4A gene variation in a Chinese pedigree affected with skeletal muscle sodium channelopathies]. Lu Y; Yang X; Wang X; Xue P; Zhang J; Li Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Aug; 36(8):809-812. PubMed ID: 31400134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]